FindTrial
Sign In

Development of DeepPGx: A Clinical Decision Support System Based on Pharmacogenomics

Development of DeepPGx: A Clinical Decision Support System Based on Pharmacogenomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104116
Enrollment
Unknown
Registered
2025-06-11
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A Clinical Decision Support System Based on PGx

Interventions

DeepPGx group:None
Expert Adjudication group:None

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Collaborate with partner hospitals or research institutions to recruit or collect 3,000 patient cases within the study scope. All data must undergo strict de-identification, removing private information including names, ID numbers, and contact details. These cases will contain critical information such as genetic testing results, medication records, diagnoses, and follow-up data to support subsequent RLHF annotation and validation.

Exclusion criteria

Exclusion criteria: Patients with unavailable pharmacogenomic information

Design outcomes

Primary

MeasureTime frame
Response Accuracy Rate;—

Countries

China

Contacts

Public ContactQu Qiang

Xiangya Hospital of Central South University

quqiang@csu.edu.cn+86 731 8432 7470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026